{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:11:55Z","timestamp":1780600315247,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00296-015-3246-9","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T13:43:11Z","timestamp":1426254191000},"page":"1555-1559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients"],"prefix":"10.1007","volume":"35","author":[{"given":"L.","family":"P\u00e9rez-Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Esquivel-Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Arana-Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vega-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Riega-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Garza-Elizondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"key":"3246_CR1","first-page":"1436","volume":"30","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hern\u00e1ndez-Garc\u00eda C, Vadillo C, Pato E, Balsa A, Gonz\u00e1lez-Alvaro I et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436\u20131439","journal-title":"J Rheumatol"},{"key":"3246_CR2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ Gomez-Reino","year":"2003","unstructured":"Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122\u20132127","journal-title":"Arthritis Rheum"},{"key":"3246_CR3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rod\u00edguez-Velarde V, Montero D, Pascual-G\u00f3mez E, Mola EM et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"key":"3246_CR4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00296-010-1441-2","volume":"32","author":"K Migita","year":"2012","unstructured":"Migita K, Umeno T, Miyagawa K, Izumi Y, Sasaki E, Kakugawa T et al (2012) on the other hand it is necessary to identify patients who do not require prophylaxis to prevent adverse events of anti-TB drugs. Rheumatol Int 32:1375\u20131377","journal-title":"Rheumatol Int"},{"key":"3246_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-010-1571-6","volume":"32","author":"M Haroon","year":"2012","unstructured":"Haroon M, Martin U, Devlin J (2012) High incidence of intolerance to tuberculosis chemoprophylaxis. Rheumatol Int 32:33\u201337","journal-title":"Rheumatol Int"},{"key":"3246_CR6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00296-010-1424-3","volume":"31","author":"T Cagatay","year":"2011","unstructured":"Cagatay T, Kilicaslan Z, Catagay P, Mertsoylu M, Gulbaran Z, Yildiz R et al (2011) TNF-alpha antagonist therapy modify the tuberculin skin test response. Rheumatol Int 31:1147\u20131151","journal-title":"Rheumatol Int"},{"key":"3246_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:625\u2013639","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3246_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.rdc.2009.03.008","volume":"35","author":"E Acevedo-V\u00e1squez","year":"2009","unstructured":"Acevedo-V\u00e1squez E, Ponce de Le\u00f3n D, Gamboa-C\u00e1rdenas R (2009) Latent infection and tuberculosis disease in rheumatoid arthritis patients. Rheum Dis Clin North Am 35:163\u2013181","journal-title":"Rheum Dis Clin North Am"},{"key":"3246_CR9","first-page":"433","volume":"8","author":"L Paimela","year":"1990","unstructured":"Paimela L, Johansson-Stephansson EA, Koskimies S, Leirisalo-Repo M (1990) Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis. Clin Exp Rheumatol 8:433\u2013437","journal-title":"Clin Exp Rheumatol"},{"key":"3246_CR10","first-page":"263","volume":"42","author":"S Coaccioli","year":"2000","unstructured":"Coaccioli S, Di Cato L, Marioli D, Patucchi E, Pizzuti C, Ponteggia M et al (2000) Impaired cutaneous cell-mediated immunity in newly diagnosed rheumatoid arthritis. Panminerva Med 42:263\u2013266","journal-title":"Panminerva Med"},{"key":"3246_CR11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"D Ponce de Le\u00f3n","year":"2005","unstructured":"Ponce de Le\u00f3n D, Acevedo-V\u00e1squez E, S\u00e1nchez-Torres A, Cucho M, Alfaro J, Perich R et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360\u20131361","journal-title":"Ann Rheum Dis"},{"key":"3246_CR12","author":"A Arana-Guajardo","year":"2014","unstructured":"Arana-Guajardo A, P\u00e9rez-Barbosa L, Vega-Morales D, Riega-Torres J, Esquivel- Valerio J, Garza-Elizondo M (2014) Application of a prediction model for the progression of rheumatoid arthritis in patients with undifferentiated arthritis. Reumatol Clin. doi: 10.1016\/j.reuma.2014.01.007","journal-title":"Reumatol Clin"},{"key":"3246_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"F Arnett","year":"1988","unstructured":"Arnett F, Edworthy S, Bloch D, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3246_CR14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"3246_CR15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ard.2008.093187","volume":"68","author":"F Banal","year":"2009","unstructured":"Banal F, Dougados M, Combescure C, Gossec L (2009) Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann Rheum Dis 68:1184\u20131191","journal-title":"Ann Rheum Dis"},{"key":"3246_CR16","unstructured":"WHO-Global tuberculosis database \u2013 2014. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ . Accessed February 23, 2015"},{"key":"3246_CR17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3899\/jrheum.090672","volume":"37","author":"C Abud-Mendoza","year":"2010","unstructured":"Abud-Mendoza C, Mart\u00ednez-Mart\u00ednez MU, Mac\u00edas-Mendoza JDJ, Maga\u00f1a-Aquino M (2010) Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries? J Rheumatol 37:672\u2013673","journal-title":"J Rheumatol"},{"key":"3246_CR18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","volume":"33","author":"F Bartalesi","year":"2009","unstructured":"Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D et al (2009) QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33:586\u2013593","journal-title":"Eur Respir J"},{"key":"3246_CR19","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Das SK, Agarwal GC, Srivastava R (2014) Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti-TNF therapies. Interdiscip Perspect Infect Dis. doi: 10.1155\/2014\/430134","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"3246_CR20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00296-009-1027-z","volume":"30","author":"MN Tamborenea","year":"2010","unstructured":"Tamborenea MN, Tate G, Mysler E, Debonis J, Schijedman A (2010) Prevalence of positive ppd in a cohort of rheumatoid arthritis patients. Rheumatol Int 30:613\u2013616","journal-title":"Rheumatol Int"},{"key":"3246_CR21","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/425916","volume":"39","author":"A Kraut","year":"2004","unstructured":"Kraut A, Coodin M, Plessis R, McLean D (2004) Predictors of positive tuberculin skin test (TST) results after 2-step TST among health care workers in Manitoba, Canada. Clin Infect Dis 39:e113\u2013e114","journal-title":"Clin Infect Dis"},{"key":"3246_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ajic.2005.12.003","volume":"34","author":"K Cengiz","year":"2006","unstructured":"Cengiz K, Seker A (2006) Boosted tuberculin skin testing in hemodialysis patients. Am J Infect Control 34:383\u2013387","journal-title":"Am J Infect Control"},{"key":"3246_CR23","first-page":"1407","volume":"12","author":"EG Teixeira","year":"2008","unstructured":"Teixeira EG, Kristski A, Ruffino-Netto A, Steffen R, Lapa E, Silva JR, Belo M et al (2008) Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students. Int J Tuberc Lung Dis 12:1407\u20131413","journal-title":"Int J Tuberc Lung Dis"},{"key":"3246_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0036-36342000000100009","volume":"42","author":"L Ostrosky-Zeichner","year":"2000","unstructured":"Ostrosky-Zeichner L, Rangel-Frausto MS, Garc\u00eda-Romero E, V\u00e1zquez A, Ibarra MJ, Ponce de Le\u00f3n-Rosales S (2000) Tuberculosis in health personnel: importance of surveillance and control programs. Salud Publica Mex 42:48\u201352","journal-title":"Salud Publica Mex"},{"key":"3246_CR25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.immunol.18.1.529","volume":"18","author":"BF Haynes","year":"2000","unstructured":"Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP (2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann Rev Immunol 18:529\u2013560","journal-title":"Ann Rev Immunol"},{"key":"3246_CR26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0531-5565(03)00090-1","volume":"38","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Fulbright JW, Goronzy JJ (2003) Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol 38:833\u2013841","journal-title":"Exp Gerontol"},{"key":"3246_CR27","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00296-011-1889-8","volume":"32","author":"KH Lee","year":"2012","unstructured":"Lee KH, Jung SY, Ha YJ, Lee SK, Park YB (2012) Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis. Rheumatol Int 32:1421\u20131424","journal-title":"Rheumatol Int"},{"key":"3246_CR28","first-page":"1","volume":"8","author":"R Lorenzetti","year":"2014","unstructured":"Lorenzetti R, Zullo A, Ridola L, Diamanti AP, Lagana B, Gatta L et al (2014) Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. Ann Med 8:1\u20138. doi: 10.3109\/07853890.2014.941919","journal-title":"Ann Med"},{"key":"3246_CR29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00296-009-1170-6","volume":"30","author":"T Catagay","year":"2010","unstructured":"Catagay T, Aydin M, Sunmez S, Catagay P, Gulbaran Z, Gul A et al (2010) Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis. Rheumatol Int 30:1459\u20131463","journal-title":"Rheumatol Int"},{"key":"3246_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2011.08.002","volume":"42","author":"N Mrozek","year":"2012","unstructured":"Mrozek N, Pereira B, Soubrier M, Gourdon F, Laurichesse H (2012) Screening of tuberculosis before biologics. Med Mal Infect 42:1\u20134","journal-title":"Med Mal Infect"},{"key":"3246_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149:177\u2013184","journal-title":"Ann Intern Med"},{"key":"3246_CR32","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1007\/s00296-011-2243-x","volume":"32","author":"I Hanta","year":"2012","unstructured":"Hanta I, Ozbek S, Kuleci S, Seydaoglu G, Ozytilmaz E (2012) Detection of latent tuberculosis infection in rheumatologic diseases before anti-TNF\u03b1 therapy: tuberculin skin test versus IFN-\u03b3 assay. Rheumatol Int 32:3599\u201335603","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3246-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3246-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:28:29Z","timestamp":1559042909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3246-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3246-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]}}}